ConductScience.org, home

Paper38737101

Therapeutic developments for neurodegenerative GM1 gangliosidosis.

Foster D and 3 others. Front Neurosci, 2024. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Therapeutic developments for neurodegenerative GM1 gangliosidosis. Papers, record 38737101. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38737101

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapeutic developments for neurodegenerative GM1 gangliosidosis.
PubMed
Journal
Front Neurosci
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
3.77, provisional
iCite
Revised in PubMed
2024-06-03
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Foster DDorian
2Williams LLucian
3Arnold NNoah
4Larsen JJessica

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R21 NS133477NINDS NIH HHSUnited StatesR21NS133477PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137526361Life-Limiting Peripheral Organ Dysfunction in Feline Sandhoff Disease Emerges after Effective CNS Gene Therapy.Ann Neurol2023https://conductscience.org/library/papers/37526361PubMed
218387328Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis.Mol Genet Metab2008https://conductscience.org/library/papers/18387328PubMed
38132559N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis.J Biol Chem1994https://conductscience.org/library/papers/8132559PubMed
410021458A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder.J Clin Invest1999https://conductscience.org/library/papers/10021458PubMed
515941905Chemokine-induced recruitment of genetically modified bone marrow cells into the CNS of GM1-gangliosidosis mice corrects neuronal pathology.Blood2005https://conductscience.org/library/papers/15941905PubMed
615262262Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease.Neurobiol Dis2004https://conductscience.org/library/papers/15262262PubMed
737298512Ganglioside GM1 and the Central Nervous System.Int J Mol Sci2023https://conductscience.org/library/papers/37298512PubMed
8319702037T MRI Predicts Amelioration of Neurodegeneration in the Brain after AAV Gene Therapy.Mol Ther Methods Clin Dev2020https://conductscience.org/library/papers/31970203PubMed
929147032Emptying the stores: lysosomal diseases and therapeutic strategies.Nat Rev Drug Discov2018https://conductscience.org/library/papers/29147032PubMed
1023689599Therapeutic response in feline sandhoff disease despite immunity to intracranial gene therapy.Mol Ther2013https://conductscience.org/library/papers/23689599PubMed
1123955157Enzyme replacement in neuronal storage disorders in the pediatric population.Curr Treat Options Neurol2013https://conductscience.org/library/papers/23955157PubMed
1215687347Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice.J Lipid Res2005https://conductscience.org/library/papers/15687347PubMed
1328577204The treatment of juvenile/adult GM1-gangliosidosis with Miglustat may reverse disease progression.Metab Brain Dis2017https://conductscience.org/library/papers/28577204PubMed
1418524657GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects.Mol Genet Metab2008https://conductscience.org/library/papers/18524657PubMed
1526766614Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion.Mol Genet Metab2016https://conductscience.org/library/papers/26766614PubMed
1631481471Intracerebroventricular enzyme replacement therapy with β-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice.J Biol Chem2020https://conductscience.org/library/papers/31481471PubMed
1717164772Complete correction of enzymatic deficiency and neurochemistry in the GM1-gangliosidosis mouse brain by neonatal adeno-associated virus-mediated gene delivery.Mol Ther2007https://conductscience.org/library/papers/17164772PubMed
1828502768Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.Adv Drug Deliv Rev2017https://conductscience.org/library/papers/28502768PubMed
1928808666Lipidomic Evaluation of Feline Neurologic Disease after AAV Gene Therapy.Mol Ther Methods Clin Dev2017https://conductscience.org/library/papers/28808666PubMed
2020976108AAV-mediated gene delivery in adult GM1-gangliosidosis mice corrects lysosomal storage in CNS and improves survival.PLoS One2010https://conductscience.org/library/papers/20976108PubMed

See all 51 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42782580Single-nucleus RNA sequencing reveals excitatory and inhibitory neuronal subtype imbalance and its potential regulatory mechanisms in GM1 gangliosidosis.Genes Genomics2026https://conductscience.org/library/papers/42782580PubMed
42410243Brain aging in Type II GM1 gangliosidosis.Commun Med (Lond)2026https://conductscience.org/library/papers/42410243PubMed
42353850Infantile GM1 Gangliosidosis with Epilepsy Associated with a Same-Codon GLB1 Variant (c.808T>G/c.808T>C).Genes (Basel)2026https://conductscience.org/library/papers/42353850PubMed
42160923Diagnostic and therapeutic applications of the glycan biomarker H3N2b in GM1 Gangliosidosis.Mol Genet Metab2026https://conductscience.org/library/papers/42160923PubMed
42074270Development of Small-Molecule Allosteric Modulators of Beta-Galactosidase (β-Gal) for the Treatment of GM1 Gangliosidosis and Morquio B.Int J Mol Sci2026https://conductscience.org/library/papers/42074270PubMed
41581874Gangliosides in molecular interactions and cell regulation.J Biol Chem2026https://conductscience.org/library/papers/41581874PubMed
40872546Systemic Metabolic Alterations Induced by Etodolac in Healthy Individuals.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40872546PubMed
40485743DANGO: An MS data annotation tool for glycolipidomics.BBA Adv2025https://conductscience.org/library/papers/40485743PubMed
40462861Differential tractography: an imaging marker for tissue degeneration in neurodegenerative diseases.Brain Commun2025https://conductscience.org/library/papers/40462861PubMed
39273659Insights into the Pathobiology of GM1 Gangliosidosis from Single-Nucleus Transcriptomic Analysis of CNS Cells in a Mouse Model.Int J Mol Sci2024https://conductscience.org/library/papers/39273659PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GLB12720PubTator's text mininghttps://conductscience.org/library/genes/2720

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38737101

GET https://conductscience.org/api/papers/v1/38737101/references?page=2